Cumberland Pharmaceuticals (CPIX) Receivables - Net (2016 - 2026)
Cumberland Pharmaceuticals' Receivables - Net history spans 16 years, with the latest figure at $16.9 million for Q4 2025.
- On a quarterly basis, Receivables - Net rose 44.81% to $16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 44.81% increase, with the full-year FY2025 number at $16.9 million, up 44.81% from a year prior.
- Receivables - Net hit $16.9 million in Q4 2025 for Cumberland Pharmaceuticals, up from $10.4 million in the prior quarter.
- Over the last five years, Receivables - Net for CPIX hit a ceiling of $16.9 million in Q4 2025 and a floor of $6.9 million in Q4 2021.
- Historically, Receivables - Net has averaged $11.9 million across 5 years, with a median of $11.7 million in 2024.
- The widest YoY moves for Receivables - Net: up 110.92% in 2021, down 44.44% in 2021.
- Tracing CPIX's Receivables - Net over 5 years: stood at $6.9 million in 2021, then skyrocketed by 91.41% to $13.2 million in 2022, then decreased by 25.87% to $9.8 million in 2023, then increased by 19.91% to $11.7 million in 2024, then skyrocketed by 44.81% to $16.9 million in 2025.
- Business Quant data shows Receivables - Net for CPIX at $16.9 million in Q4 2025, $10.4 million in Q3 2025, and $10.3 million in Q2 2025.